Abstract:The field of Membrane Protein Structural Biology has grown significantly since its first landmark in 1985 with the first three-dimensional atomic resolution structure of a membrane protein. Nearly twenty-six years later, the crystal structure of the beta2 adrenergic receptor in complex with G protein has contributed to another landmark in the field leading to the 2012 Nobel Prize in Chemistry. At present, more than 350 unique membrane protein structures solved by X-ray crystallography (http://blanco.biomol.uci.edu/mpstruc/exp/list, Stephen White Lab at UC Irvine) are available in the Protein Data Bank. The advent of genomics and proteomics initiatives combined with high-throughput technologies, such as automation, miniaturization, integration and third-generation synchrotrons, has enhanced membrane protein structure determination rate. X-ray crystallography is still the only method capable of providing detailed information on how ligands, cofactors, and ions interact with proteins, and is therefore a powerful tool in biochemistry and drug discovery. Yet the growth of membrane protein crystals suitable for X-ray diffraction studies amazingly remains a fine art and a major bottleneck in the field. It is often necessary to apply as many innovative approaches as possible. In this review we draw attention to the latest methods and strategies for the production of suitable crystals for membrane protein structure determination. In addition we also highlight the impact that third-generation synchrotron radiation has made in the field, summarizing the latest strategies used at synchrotron beamlines for screening and data collection from such demanding crystals. This article is part of a Special Issue entitled: Structural and biophysical characterisation of membrane protein-ligand binding.

Crystallizing Thinking about the Beta 2-Adrenergic Receptor

Crystallizing Thinking about the Beta2-Adrenergic Receptor.

Structural Insights into Ligand Recognition and Activation of Angiotensin Receptors.

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Conformational changes in the G protein Gs induced by the β2 adrenergic receptor

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

Discovery of New GPCR Biology: One Receptor Structure at a Time

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Cryo-EM structure of the human adenosine A 2B receptor-G s signaling complex.

[Single-Particle Cryo-Electron Microscopy Opens New Avenues in Structural Biology of G Protein-Coupled Receptor].

Structure of a nanobody-stabilized active state of the β2 adrenoceptor

Chemical Synthesis of a Full-Length G-Protein-Coupled Receptor Β2-Adrenergic Receptor with Defined Modification Patterns at the C-Terminus.

Analysis of <sub>2</sub>AR-G<sub>s</sub> and <sub>2</sub>AR-G<sub>i</sub> complex formation by NMR spectroscopy

Chemical Synthesis of a Full-Length G-Protein-Coupled Receptor β 2 -Adrenergic Receptor with Defined Modification Patterns at the C-Terminus

Evolutionary Trace and Molecular Dynamics Simulation of the Beta2 Adrenergic Receptor Mutation-induced Activation

Universal Properties and Specificities of the β2-Adrenergic Receptor-Gs Protein Complex Activation Mechanism Revealed by All-Atom Molecular Dynamics Simulations

Advances in Receptor Conformation Research: the Quest for Functionally Selective Conformations Focusing on the Β2-Adrenoceptor.

Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

Crystal structure of a human GABAA receptor

Membrane protein structure determination — The next generation